Society for Clinical Research Sites Launches the Site Advocacy Group Initiative - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Society for Clinical Research Sites Launches the Site Advocacy Group Initiative

Source: Applied Clinical Trials

The Society for Clinical Research Sites (SCRS) has launched its newest initiative, the Site Advocacy Group (SAG), with TransCelerate BioPharma as its SAG partner.

The SAG initiative consists of SCRS members representing a broad spectrum of site professionals and clinical research sites who will partner with TransCelerate workstream members to exchange practical feedback on various topics. In return, industry leaders will share with the sites their key priorities and initiatives to elevate the ecosystem. It is hoped that the knowledge gained will help to promote site sustainability, enhance clinical research effectiveness and more closely align the work of the sites and industry across the research ecosystem.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here